• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克拉霉素胃滞留剂型的制剂与评价

Formulation and evaluation of gastroretentive dosage forms of Clarithromycin.

作者信息

Nama Muralidhar, Gonugunta Chandra Sekhar Rao, Reddy Veerareddy Prabhakar

机构信息

Pharmaceutics, St. Peter's Institute of Pharmaceutical Sciences, Warangal, Andhra Pradesh, India.

出版信息

AAPS PharmSciTech. 2008;9(1):231-7. doi: 10.1208/s12249-008-9038-8. Epub 2008 Feb 7.

DOI:10.1208/s12249-008-9038-8
PMID:18446486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2976904/
Abstract

The purpose of this research was to develop the hydrodynamically balanced delivery system of Clarithromycin (CLA) which, after oral administration should have the ability to prolong gastric residence time with the desired in vitro release profile for the localized action in the stomach, in the treatment of Helicobacter pylori (H.pylori) mediated peptic ulcer. By applying wet granulation technique floating tablets of Clarithromycin were prepared. The proportion of sodium bicarbonate was varied to get the least possible lag time, also the polymer part varied to get the desired release. In vivo radiographic studies were performed with Barium sulphate loaded formulation to justify the increased gastric residence time of the dosage form in the stomach, based on the floating principle. The formulation developed using 66.2% Clarithromycin, 12% HPMC K4M polymer, 8% sodium bicarbonate gave floating lag time less than 3 min with a floating time of 12 h, and an in vitro release profile very near to the desired release. X-ray studies showed the enhanced gastric residence time of the tablet to 220 +/- 30 min. The mechanism of release of Clarithromycin from the floating tablets is anomalous diffusion transport and follows zero order kinetics. In vivo radiographic studies suggest that the tablet has increased gastric residence time for the effective localized action of the antibiotic (Clarithromycin) in the treatment of H.pylori mediated peptic ulcer.

摘要

本研究的目的是开发一种克拉霉素(CLA)的流体动力学平衡给药系统,口服后应能够延长胃滞留时间,并具有理想的体外释放曲线,以便在胃中发挥局部作用,用于治疗幽门螺杆菌(H.pylori)介导的消化性溃疡。通过应用湿法制粒技术制备了克拉霉素漂浮片。改变碳酸氢钠的比例以获得尽可能短的滞后时间,同时改变聚合物部分以获得所需的释放效果。使用负载硫酸钡的制剂进行体内放射学研究,以证明基于漂浮原理的剂型在胃中的胃滞留时间增加。使用66.2%克拉霉素、12%羟丙甲纤维素K4M聚合物、8%碳酸氢钠开发的制剂的漂浮滞后时间小于3分钟,漂浮时间为12小时,体外释放曲线非常接近所需释放曲线。X射线研究表明片剂在胃中的滞留时间延长至220±30分钟。克拉霉素从漂浮片中的释放机制为非菲克扩散转运,遵循零级动力学。体内放射学研究表明,该片剂在治疗H.pylori介导的消化性溃疡中,由于抗生素(克拉霉素)的有效局部作用而增加了胃滞留时间。

相似文献

1
Formulation and evaluation of gastroretentive dosage forms of Clarithromycin.克拉霉素胃滞留剂型的制剂与评价
AAPS PharmSciTech. 2008;9(1):231-7. doi: 10.1208/s12249-008-9038-8. Epub 2008 Feb 7.
2
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.克拉霉素多单元漂浮药物递送系统的研发:制剂、采用改良溶出装置的体外溶出度研究、人体志愿者体内影像学研究
Drug Res (Stuttg). 2017 Jul;67(7):412-418. doi: 10.1055/s-0043-102952. Epub 2017 Apr 27.
3
Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori.含克拉霉素的幽门螺杆菌漂浮药物递送系统的制剂与评价
Acta Pol Pharm. 2006 Jan-Feb;63(1):53-61.
4
Optimization and evaluation of clarithromycin floating tablets using experimental mixture design.采用实验混合设计优化与评价克拉霉素胃漂浮片
Acta Pol Pharm. 2014 Mar-Apr;71(2):311-21.
5
Development and evaluation of gastroretentive norfloxacin floating tablets.胃滞留型诺氟沙星漂浮片的研制与评价
Acta Pharm. 2009 Jun;59(2):211-21. doi: 10.2478/v10007-009-0019-6.
6
Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection.用于治疗幽门螺杆菌感染的克拉霉素胃内漂浮型粘膜粘附微球
Chem Pharm Bull (Tokyo). 2010 Jun;58(6):782-7. doi: 10.1248/cpb.58.782.
7
Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.盐酸维拉帕米胃内漂浮片的研制及其体内漂浮行为
AAPS PharmSciTech. 2009;10(1):310-5. doi: 10.1208/s12249-009-9210-9. Epub 2009 Mar 19.
8
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.用于根除幽门螺杆菌的基于美丽决明子的三水合阿莫西林漂浮型生物黏附胃滞留微丸。
Drug Deliv. 2016;23(2):405-19. doi: 10.3109/10717544.2014.916766. Epub 2014 May 28.
9
Development of bilayer floating tablet of amoxicillin and Aloe vera gel powder for treatment of gastric ulcers.双层漂浮片的研制阿莫西林和芦荟凝胶粉治疗胃溃疡。
AAPS PharmSciTech. 2012 Dec;13(4):1518-23. doi: 10.1208/s12249-012-9882-4. Epub 2012 Nov 8.
10
Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets.盐酸环丙沙星胃内滞留型膨胀漂浮片的处方设计与评价
AAPS PharmSciTech. 2009;10(1):220-6. doi: 10.1208/s12249-009-9200-y. Epub 2009 Mar 10.

引用本文的文献

1
Assessing the Synergistic Activity of Clarithromycin and Therapeutic Oils Encapsulated in Sodium Alginate Based Floating Microbeads.评估克拉霉素与包裹于海藻酸钠基漂浮微珠中的治疗性油的协同活性。
Microorganisms. 2022 Jun 7;10(6):1171. doi: 10.3390/microorganisms10061171.
2
Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin.埃索美拉唑和克拉霉素控释漂浮双层片的制备与表征。
Molecules. 2022 May 18;27(10):3242. doi: 10.3390/molecules27103242.
3
Preparation and Characterization of pH-Independent Sustained-Release Tablets Containing Hot Melt Extruded Solid Dispersions of Clarithromycin : Tablets Containing Solid Dispersions of Clarithromycin.克拉霉素热熔挤出固体分散体的 pH 非依赖性缓释片的制备与表征:含克拉霉素固体分散体的片剂。
AAPS PharmSciTech. 2021 Nov 12;22(8):275. doi: 10.1208/s12249-021-02115-6.
4
Integrated lipidomic and transcriptomic analysis reveals clarithromycin-induced alteration of glycerophospholipid metabolism in the cerebral cortex of mice.综合脂质组学和转录组学分析揭示克拉霉素诱导的小鼠大脑皮层甘油磷脂代谢改变。
Cell Biol Toxicol. 2023 Jun;39(3):771-793. doi: 10.1007/s10565-021-09646-5. Epub 2021 Aug 30.
5
Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming.基于熔融发泡法的胃滞留固体制剂的研制与特性研究。
AAPS PharmSciTech. 2019 Aug 19;20(7):290. doi: 10.1208/s12249-019-1500-2.
6
Stomach-Specific Drug Delivery of Clarithromycin Using a Semi Interpenetrating Polymeric Network Hydrogel Made of Montmorillonite and Chitosan: Synthesis, Characterization and In Vitro Drug Release Study.使用蒙脱石和壳聚糖制成的半互穿聚合物网络水凝胶实现克拉霉素的胃特异性药物递送:合成、表征及体外药物释放研究
Adv Pharm Bull. 2019 Feb;9(1):159-173. doi: 10.15171/apb.2019.019. Epub 2019 Feb 21.
7
Dissolution rate enhancement of clarithromycin using ternary ground mixtures: nanocrystal formation.使用三元研磨混合物提高克拉霉素的溶出速率:纳米晶体的形成
Iran J Pharm Res. 2013 Fall;12(4):587-98.
8
Development of bilayer floating tablet of amoxicillin and Aloe vera gel powder for treatment of gastric ulcers.双层漂浮片的研制阿莫西林和芦荟凝胶粉治疗胃溃疡。
AAPS PharmSciTech. 2012 Dec;13(4):1518-23. doi: 10.1208/s12249-012-9882-4. Epub 2012 Nov 8.

本文引用的文献

1
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.1. 药物递送分析指数模型述评:原创研究文章:溶质释放描述的一个简单方程:I II. 平板、球体、圆柱体或圆盘形式的非溶胀装置中的菲克和非菲克释放,1987年。
J Control Release. 2014 Sep 28;190:31-2.
2
Swelling, erosion and release behavior of alginate-based matrix tablets.藻酸盐基骨架片的溶胀、侵蚀及释放行为
Eur J Pharm Biopharm. 2007 Jun;66(3):435-50. doi: 10.1016/j.ejpb.2006.12.003. Epub 2006 Dec 16.
3
Gastroretentive dosage forms: overview and special case of Helicobacter pylori.胃滞留剂型:概述及幽门螺杆菌的特殊情况
J Control Release. 2006 Mar 10;111(1-2):1-18. doi: 10.1016/j.jconrel.2005.10.031. Epub 2006 Jan 5.
4
Floating drug delivery systems: a review.漂浮药物递送系统:综述
AAPS PharmSciTech. 2005 Oct 19;6(3):E372-90. doi: 10.1208/pt060347.
5
Modeling of drug release from swellable polymers.
Eur J Pharm Biopharm. 2000 Jan;49(1):47-58. doi: 10.1016/s0939-6411(99)00058-2.
6
Clarithromycin clinical pharmacokinetics.克拉霉素的临床药代动力学。
Clin Pharmacokinet. 1993 Sep;25(3):189-204. doi: 10.2165/00003088-199325030-00003.